Chemspec-API formed as joint venture of Shanghai Chemspec Corp. and API Inc., providing clients with a US manufacturer of APIs and pharmaceutical intermediates with access to extensive resources at Shanghai Chemspec.
Chemspec-API today announced its formation as a joint venture of Shanghai Chemspec Corp. and API Inc. The agreement between the two companies means that API Inc.’s Fairfield facility will operate as Chemspec-API, providing process research and development, cGMP production and CMC services. In addition to this, clients will now have seamless access to resources at Shanghai Chemspec with project management at Fairfield.